|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-0-387-34573-4 |
003 |
DE-He213 |
005 |
20220114123512.0 |
007 |
cr nn 008mamaa |
008 |
100301s2006 xxu| s |||| 0|eng d |
020 |
|
|
|a 9780387345734
|9 978-0-387-34573-4
|
024 |
7 |
|
|a 10.1007/0-387-34573-6
|2 doi
|
050 |
|
4 |
|a QR180-189.5
|
072 |
|
7 |
|a MJCM
|2 bicssc
|
072 |
|
7 |
|a MED044000
|2 bisacsh
|
072 |
|
7 |
|a MJCM
|2 thema
|
082 |
0 |
4 |
|a 571.96
|2 23
|
082 |
0 |
4 |
|a 616.079
|2 23
|
245 |
1 |
0 |
|a Fas Signaling
|h [electronic resource] /
|c edited by Harald Wajant.
|
250 |
|
|
|a 1st ed. 2006.
|
264 |
|
1 |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2006.
|
300 |
|
|
|a VIII, 160 p. 32 illus., 4 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Medical Intelligence Unit
|
505 |
0 |
|
|a FasL and Fas -- FasL-Independent Activation of Fas -- Role of Ceramide in CD95 Signaling -- Regulation of Fas Signaling by FLIP Proteins -- Fas-Induced Necrosis -- Fas-More Than an Apoptosis Inducer -- Retrograde Fas Ligand Signaling -- FasL and Fas in Liver Homeostasis and Hepatic Injuries -- Fas-Activation, Development and Homeostasis of T Cells -- The FasL-Fas System in Disease and Therapy -- Tools for Activation and Neutralization of Fas Signaling.
|
520 |
|
|
|a Fas Signaling is focused on the signaling mechanisms and biology of the prototypic death receptor Fas, also called CD95 or APO-1. The chapters of this book cover, besides the well recognized apoptosis-related functions of Fas, its emerging role as a proinflammatory cytokine and as an inducer of alternative forms of cell death. Fas Signaling aims to provide the reader with an up-to-date survey of the various aspects of Fas biology and the open questions of the field are addressed. This title is intended for Ph.D and post-doctoral students starting to work in the field, but is also useful for everyone with an interest in the biology of this exciting molecule.
|
650 |
|
0 |
|a Immunology.
|
650 |
|
0 |
|a Medicine-Research.
|
650 |
|
0 |
|a Biology-Research.
|
650 |
|
0 |
|a Oncology.
|
650 |
1 |
4 |
|a Immunology.
|
650 |
2 |
4 |
|a Biomedical Research.
|
650 |
2 |
4 |
|a Oncology.
|
700 |
1 |
|
|a Wajant, Harald.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9781441940742
|
776 |
0 |
8 |
|i Printed edition:
|z 9780387512105
|
776 |
0 |
8 |
|i Printed edition:
|z 9780387321721
|
830 |
|
0 |
|a Medical Intelligence Unit
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/0-387-34573-6
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SBL
|
912 |
|
|
|a ZDB-2-SXB
|
950 |
|
|
|a Biomedical and Life Sciences (SpringerNature-11642)
|
950 |
|
|
|a Biomedical and Life Sciences (R0) (SpringerNature-43708)
|